Motley Fool Australia
  •  
  • Log Out
  • Menu
  1. Stocks
    2. /
  2. Radiopharm Theranostics Limited (ASX: RAD)
    3. /

Radiopharm Theranostics Limited (ASX: RAD) Share Price and News

Price

$0.022

Movement

0.00 (0.0)

as at 20 Nov - Closed (20 mins delayed)

52 Week Range

$0.019 - $0.042

 
1 Year Return

-15.38%

Radiopharm Theranostics Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

$0.022

Day Change

0.00 (0.0)

52 Week Range

$0.019 - $0.042

Yesterday's Close

$0.022

Today's Open

–

Days Range

– - –

Volume

0

Avg. Volume (1 month)

8,976,323

Turnover

$0

as at 20 Nov - Closed

    • Radiopharm Theranostics Limited (ASX: RAD)
    Latest News

    Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
    Healthcare Shares

    This biotechnology stock just ticked over 100% gains for the month on more good news

    | Cameron England

    Two drug development agreements in under a month have caused this junior biotech's shares to surge.

    Read more »

    A boy stands firm on a rocky cliff holding a rocket in each hand and looking up toward the sky, anticipating flying into space.
    Small Cap Shares

    2 ASX small-cap shares rocketing 35% to 54% today

    | Bernd Struben

    Two soaring ASX small-cap shares are setting the bar high on Friday.

    Read more »

    one hundred dollar notes planted in the ground representing growth asx shares
    Small Cap Shares

    'Richest pipeline' in ASX: Expert names 3 small-cap shares to buy

    | Tony Yoo

    Ask A Fund Manager: Alto Capital's Tony Locantro also reveals what his biggest regret in investing is.

    Read more »

    RAD ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    19th Nov 2025 2025-11-19T12:43:48 Initial Director's Interest NoticeYesNo12:43pm2284k
    19th Nov 2025 2025-11-19T12:43:23 Life Sciences Leader Bruce Goodwin Appointed to BoardYesNo12:43pm2234k
    18th Nov 2025 2025-11-18T08:31:13 RAD Approval for Phase 1 Therapeutic Trial of RAD 402YesNo8:31am2113k
    17th Nov 2025 2025-11-17T08:28:34 RAD Announces 50% Enrollment in Phase 2b Trial of RAD101YesNo8:28am3118k
    12th Nov 2025 2025-11-12T10:35:45 RAD starts enrollment of 3rd Cohort of Phase 1 177Lu-RAD204YesNo10:35am2114k
    6th Nov 2025 2025-11-06T11:18:25 Disclosure of Long Equity Derivative PositionsYesNo11:18am3193k
    4th Nov 2025 2025-11-04T09:17:41 Notice of Extraordinary General Meeting and Proxy FormYesNo9:17am18282k
    3rd Nov 2025 2025-11-03T12:17:18 Presenting at Deutsche Bank ADR Virtual Investor ConferenceYesNo12:17pm3235k
    3rd Nov 2025 2025-11-03T10:53:17 Change of Director's Interest Notice (RC)YesNo10:53am3508k
    28th Oct 2025 2025-10-28T19:46:48 Change in substantial holdingYesNo7:46pm4225k

    Profile

    since

    Note